Tonix Pharmaceuticals Holding Corp (TNXP)
0.737
0.00 (0.00%)
USD |
NASDAQ |
Jul 02, 16:00
0.7424
+0.01
(+0.73%)
After-Hours: 07:00
Tonix Pharmaceuticals SG&A Expense (TTM): 36.67M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 36.67M |
December 31, 2023 | 34.75M |
September 30, 2023 | 31.18M |
June 30, 2023 | 29.86M |
March 31, 2023 | 29.59M |
December 31, 2022 | 30.22M |
September 30, 2022 | 29.34M |
June 30, 2022 | 27.41M |
March 31, 2022 | 26.08M |
December 31, 2021 | 23.47M |
September 30, 2021 | 21.22M |
June 30, 2021 | 18.95M |
March 31, 2021 | 17.14M |
December 31, 2020 | 14.35M |
September 30, 2020 | 12.47M |
June 30, 2020 | 12.12M |
March 31, 2020 | 10.86M |
December 31, 2019 | 10.64M |
September 30, 2019 | 10.18M |
June 30, 2019 | 9.623M |
March 31, 2019 | 9.347M |
December 31, 2018 | 8.764M |
September 30, 2018 | 8.08M |
June 30, 2018 | 7.73M |
March 31, 2018 | 7.67M |
Date | Value |
---|---|
December 31, 2017 | 7.949M |
September 30, 2017 | 8.67M |
June 30, 2017 | 8.886M |
March 31, 2017 | 9.19M |
December 31, 2016 | 10.44M |
September 30, 2016 | 11.72M |
June 30, 2016 | 12.54M |
March 31, 2016 | 13.13M |
December 31, 2015 | 12.66M |
September 30, 2015 | 11.98M |
June 30, 2015 | 11.23M |
March 31, 2015 | 10.29M |
December 31, 2014 | 9.039M |
September 30, 2014 | 8.191M |
June 30, 2014 | 7.429M |
March 31, 2014 | 6.597M |
December 31, 2013 | 6.238M |
September 30, 2013 | 5.073M |
June 30, 2013 | 4.694M |
March 31, 2013 | 4.575M |
December 31, 2012 | 4.078M |
September 30, 2012 | 3.833M |
June 30, 2012 | 3.279M |
March 31, 2012 | 2.549M |
December 31, 2011 | 2.220M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
10.18M
Minimum
Sep 2019
36.67M
Maximum
Mar 2024
22.45M
Average
23.47M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
ThermoGenesis Holdings Inc | 6.925M |
Assure Holdings Corp | 14.30M |
Vigil Neuroscience Inc | 28.08M |
Allakos Inc | 44.08M |
RAPT Therapeutics Inc | 27.81M |